Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,789
Closed -$203K 106
2024
Q3
$203K Sell
1,789
-75
-4% -$8.91K 0.06% 170
2024
Q2
$231K Buy
+1,864
New +$240K 0.04% 218
2023
Q1
Sell
-6,422
Closed -$693K 510
2022
Q4
$713K Buy
+6,422
New +$656K 0.07% 213
2022
Q2
Sell
-5,088
Closed -$417K 445
2022
Q1
$417K Buy
+5,088
New +$401K 0.07% 82
2021
Q2
Sell
-5,481
Closed -$408K 505
2021
Q1
$403K Sell
5,481
-4,005
-42% -$295K 0.02% 104
2020
Q4
$740K Buy
9,486
+2,049
+28% +$157K 0.05% 63
2020
Q3
$589K Sell
7,437
-480
-6% -$37.6K 0.05% 45
2020
Q2
$584K Sell
7,917
-422
-5% -$31.8K 0.07% 59
2020
Q1
$612K Buy
8,339
+5,671
+213% +$446K 0.04% 50
2019
Q4
$232K Buy
+2,668
New +$219K 0.03% 117
2019
Q2
Sell
-9,630
Closed -$764K 328
2019
Q1
$764K Buy
+9,630
New +$720K 0.1% 53

Other funds holding MRK

XR Securities's MRK Position: Q4 2024 in Review

XR Securities sold out of Merck (MRK) in Q4 2024, closing a stake of 1,789 shares — an estimated $203K sold.

XR Securities first reported a position in MRK in Q1 2019 and held it in 11 quarters. The position peaked at $764K in Q1 2019. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • XR Securities reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • XR Securities sold 1,789 Merck shares in Q4 2024, an estimated $203K.
  • XR Securities first reported a position in Merck in Q1 2019 and held it in 11 quarters.
  • XR Securities's Merck position peaked at $764K in Q1 2019.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on XR Securities's 13F filing for Q4 2024, filed 17 Jan 2025.